KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables (2020 - 2026)

Organon has reported Receivables over the past 7 years, most recently at $1.4 billion for Q1 2026.

  • For Q1 2026, Receivables fell 5.01% year-over-year to $1.4 billion; the TTM value through Mar 2026 reached $1.4 billion, down 5.01%, while the annual FY2025 figure was $1.3 billion, 1.99% down from the prior year.
  • Receivables for Q1 2026 was $1.4 billion at Organon, up from $1.3 billion in the prior quarter.
  • Over five years, Receivables peaked at $1.9 billion in Q2 2022 and troughed at $1.3 billion in Q4 2025.
  • A 5-year average of $1.6 billion and a median of $1.6 billion in 2023 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 66.34% in 2022 and fell as far as 23.22% in 2022.
  • Year by year, Receivables stood at $1.8 billion in 2022, then dropped by 5.68% to $1.7 billion in 2023, then fell by 22.13% to $1.4 billion in 2024, then fell by 1.99% to $1.3 billion in 2025, then increased by 3.98% to $1.4 billion in 2026.
  • Business Quant data shows Receivables for OGN at $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.5 billion in Q3 2025.